Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
HKEX:2696
Shanghai Henlius Biotech, Inc. Class H (2696) Stock Price & Analysis
0 Followers
2696 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$9.60 - HK$23.05
Previous CloseHK$22.85
Volume1.81M
Average Volume (3M)1.06M
Market Cap
HK$12.42B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)20.6
Beta0.84
Next Earnings
Aug 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.11
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,056,035
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$20.33Price Target Upside-11.03% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Shanghai Henlius Biotech, Inc. Class H News
PremiumCompany Announcements
Henlius Biotech Launches Phase 3 Cancer Trial in Japan
PremiumCompany Announcements
Henlius Biotech Welcomes New CFO Yingbo Mao
PremiumCompany Announcements
Henlius Biotech’s Promising Biosimilar Advances
PremiumCompany Announcements
Henlius Biotech Announces Merger and Privatization
PremiumCompany Announcements
Henlius Biotech’s HLX14 Biosimilar Advances in Europe
PremiumCompany Announcements
Henlius Biotech H Shares Trading Halted
PremiumCompany Announcements
Henlius Biotech Expands HANDAYUAN IndicationsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.02% Mutual Funds
0.11% Other Institutional Investors
98.87% Public Companies and
Individual Investors
2696 FAQ
What was Shanghai Henlius Biotech, Inc. Class H’s price range in the past 12 months?
Shanghai Henlius Biotech, Inc. Class H lowest stock price was HK$9.60 and its highest was HK$23.05 in the past 12 months.
What is Shanghai Henlius Biotech, Inc. Class H’s market cap?
Currently, no data Available
When is Shanghai Henlius Biotech, Inc. Class H’s upcoming earnings report date?
Shanghai Henlius Biotech, Inc. Class H’s upcoming earnings report date is Aug 15, 2024 which is in 43 days.
How were Shanghai Henlius Biotech, Inc. Class H’s earnings last quarter?
Shanghai Henlius Biotech, Inc. Class H released its earnings results on Mar 21, 2024. The company reported HK$0.275 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.275.
Is Shanghai Henlius Biotech, Inc. Class H overvalued?
According to Wall Street analysts Shanghai Henlius Biotech, Inc. Class H’s price is currently Overvalued.
Does Shanghai Henlius Biotech, Inc. Class H pay dividends?
Shanghai Henlius Biotech, Inc. Class H does not currently pay dividends.
What is Shanghai Henlius Biotech, Inc. Class H’s EPS estimate?
Shanghai Henlius Biotech, Inc. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Henlius Biotech, Inc. Class H have?
Shanghai Henlius Biotech, Inc. Class H has 163,428,540 shares outstanding.
What happened to Shanghai Henlius Biotech, Inc. Class H’s price movement after its last earnings report?
Shanghai Henlius Biotech, Inc. Class H reported an EPS of HK$0.275 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.282%.
Which hedge fund is a major shareholder of Shanghai Henlius Biotech, Inc. Class H?
Currently, no hedge funds are holding shares in HK:2696
---
Shanghai Henlius Biotech, Inc. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
28.32%
Trailing 12-Months
Asset Growth
8.82%
Trailing 12-Months
2696 Stock 12 Month Forecast
Average Price Target
HK$20.33
▼(-11.03% Downside)
Technical Analysis
Best Analysts Covering 2696
1 Year
1 Year Success Rate
4/4 ratings generated profit
1 Year Average Return
+68.58%
reiterated a buy rating 2 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +68.58% per trade.
---